TECHWIRE 30
(CIX: WRAL30)  1,082.72  down arrow-14.49  (-1.32 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NQ: Apple)  109.27  down arrow-1.1  (-1 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NY: QUINTILES)  72.78  down arrow-1.56  (-2.1 %)  Updated: 06:40 PM EDT, Sep 04 2015
(OP: BASF SE)  77.53  down arrow-1.28  (-1.62 %)  Updated: 05:20 PM EDT, Sep 04 2015
(NQ: BioCryst)  11.52  up arrow+0.39  (3.5 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NQ: BioDelivery)  6.37  up arrow+0.14  (2.25 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NQ: CEMP)  33.61  up arrow+0.13  (0.39 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NQ: Cisco)  25.52  down arrow-0.38  (-1.47 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NQ: Cree)  25.85  down arrow-0.62  (-2.34 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NQ: DARA)  0.84  up arrow+0.03  (3.07 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NY: EMC)  23.67  down arrow-0.5  (-2.07 %)  Updated: 06:40 PM EDT, Sep 04 2015
(NQ: Extreme Networks)  3.13  down arrow-0.06  (-1.88 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NQ: Facebook)  88.26  up arrow+0.11  (0.12 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NY: GLAXOSMITHKLINE)  39.69  down arrow-0.93  (-2.29 %)  Updated: 06:40 PM EDT, Sep 04 2015
(NQ: Google)  600.70  down arrow-5.55  (-0.92 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NY: IBM)  143.70  down arrow-3.08  (-2.1 %)  Updated: 06:40 PM EDT, Sep 04 2015
(NY: LH)  116.39  down arrow-1.13  (-0.96 %)  Updated: 06:40 PM EDT, Sep 04 2015
(OP: Lenovo Group)  16.07  up arrow+0.21  (1.32 %)  Updated: 05:20 PM EDT, Sep 04 2015
(NY: MRK)  51.59  down arrow-1.06  (-2.01 %)  Updated: 06:40 PM EDT, Sep 04 2015
(NQ: Microsoft)  42.61  down arrow-0.89  (-2.05 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NQ: NetApp)  30.57  down arrow-0.62  (-1.99 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NY: NOVARTIS AG)  94.55  down arrow-0.81  (-0.85 %)  Updated: 06:40 PM EDT, Sep 04 2015
(OP: Novozymes A/S)  43.08  down arrow-0.45  (-1.03 %)  Updated: 05:20 PM EDT, Sep 04 2015
(NY: Pfizer)  31.37  down arrow-0.52  (-1.63 %)  Updated: 06:40 PM EDT, Sep 04 2015
(NQ: Pozen)  8.43  down arrow-0.17  (-1.98 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NY: Red Hat)  68.66  down arrow-1.02  (-1.46 %)  Updated: 06:40 PM EDT, Sep 04 2015
(NQ: BBRY)  7.28  down arrow-0.18  (-2.41 %)  Updated: 08:10 PM EDT, Sep 04 2015
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  11.00  down arrow-0.26  (-2.31 %)  Updated: 08:10 PM EDT, Sep 04 2015

Posts tagged “N.C. Biotech Center”

4:55 p.m. Monday

Tiny Durham drug firm's megadeal: Scioderm sale may approach $1 billion

Durham-based Scioderm will be acquired by Amicus Therapeutics of Cranbury, N.J., for $229 million, and the deal could grow to nearly $1 billion if Scioderm's lead drug compound achieves certain clinical, regulatory and sales milestones.

Rafaella Kopelan, who suffers from rare "butterfly children" disease Rafaella Kopelan, who suffers from rare "butterfly children" disease

5:33 a.m. Monday

Speak up: Send WTW your news - and your opinions

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

August 28

Behind $1.85B Novo Nordisk deal: It takes a quiet team effort

When a chorus of cheers accompanies announcements like the $1.85 billion Novo Nordisk expansion in Clayton, the echo is a reminder: it only happens because a lot of behind-the-scenes work quietly makes it possible.

Novo Nordisk Clayton plant Novo Nordisk Clayton plant

August 24

We want your news - and your opinions: Share them with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated August 21

Growing fast: RTP startup AgBiome to add staff, sales team, move into new facilities

Only two years after it raised $17.5 million in venture capital, AgBiome of Research Triangle Park announced today it has raised an additional $34.5 million to fund research and the projected launch of its first product, a natural fungicide for crops and turf grasses. Yes, the RTP startup is growing fast.

AgBiome's future home in RTP AgBiome's future home in RTP

August 20

Chapel Hill-based Cempra secures FDA fast-track status for pneumonia drug

Cempra, a clinical-stage pharmaceutical company in Chapel Hill, has received fast track designation from the U.S. Food and Drug Administration for solithromycin, an antibiotic for treating community-acquired bacterial pneumonia

Cempra's pipeline Cempra's pipeline

August 17

Seund us your news - and your opinions: Share them with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated August 13

RTP's G1 Therapeutics begins clinical trials of chemoprotectant in lung cancer patients

G1 Therapeutics, a Research Triangle Park clinical-stage oncology company backed by Fred Eshelman, has begun two clinical trials of a new therapy aimed at protecting the bone marrow and immune systems of patients undergoing chemotherapy for small-cell lung cancer.

G1 Therapeutics G1 Therapeutics

August 10

We want your news - and your opinions: Share them with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated August 4

Premium Lock Greenville firm takes fingerprints to new forensic levels

A new Fingerprint Molecular Identification (FMID) technology that can divulge a suspect's gender, use of tobacco, medicines and illicit drugs, and exposure to explosives is being introduced this week by ArroGen Group, a Greenville firm, at the International Association for Identification's educational conference in Sacramento, Calif.

Forensics breakthrough? Forensics breakthrough?

August 3

Premium Lock WRAL TechWire wants your news - and your opinions: Share them with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

July 31

Premium Lock Good times, hard times ... Biogen celebrates 20 years in Research Triangle Park

There were jokes. There were fond reminiscences. There were stories about hard times endured and challenges overcome. But most of all, there were testaments of great pride and appreciation from the leaders who shaped, nurtured and built Biogen's giant Research Triangle Park biomanufacturing campus into one of the world's leading biotechnology manufacturing sites.

Remembering 20 years of Biogen in RTP Remembering 20 years of Biogen in RTP

Updated July 29

Premium Lock Newborn health screening firm nabs $13M

Durham-based Baebies, a health-screening startup, has raised $13 million in equity financing, the company said Monday. Backers include Rex Health Ventures, Duke Angel Network, Duke University's DUMAC, and the NC Biotechnology Center.

July 28

Premium Lock Cary-based Plasma solutions firm seeks $1.5M

Atmospheric Plasma Solutions, a Cary-based company with strategic ties to North Carolina State University is seeking $1.5 million in equity, according to a regulatory filing. It uses plasma technology to enable a wide range of materials processing options that may otherwise be out of reach, such as a process that previously required costly and dangerous chemicals or high temperatures.

Atmospheric Plasma Solutions coating removal. Atmospheric Plasma Solutions coating removal.

July 24

Premium Lock VBX CEO on "Buzz of Bio" pitch to global hitters

David Mann, CEO, Vascular Biosciences As the CEO of Vascular Biosciences (VBS), I was very excited to be notified by the Biotechnology Innovation Organization (BIO) that our company was the 2015 "Buzz of BIO" award winner in the "Pipelines of Promise" category.

July 23

Premium Lock Triangle jumps to No. 2 in life science hub rankings

Biotech & Life Science North Carolina's Raleigh-Durham region, a.k.a. the Research Triangle, has the nation's second leading life science base among major metro areas, up from No. 4 since last year, according to a new report.

July 21

Premium Lock NC Biotech Center awards $1.8M in loans, grants across state

N.C. Biotech Center    The numbers are in for the most recent quarter and the end of fiscal 2015: The N.C. Biotechnology Center reports awarding $1.8 million in grants and loans for the most recent quarter, adding up to nearly $6.8 million for the year.

July 21

Premium Lock In her own words: Mary-Dell Chilton's path to greatness, and her call to action

Dr. Mary-Dell Chilton hasn't yet won a Nobel Prize. Yet. But her trophy case is already full of bioscience biggies. This year, for example, she was finally inducted into the National Inventors Hall of Fame. And she was made a World Food Prize laureate in 2013. In 2002 she received the Benjamin Franklin Medal from the Franklin Institute in Philadelphia, joining a roster of winners including Alexander Graham Bell, Thomas Edison, Pierre and Marie Curie, Albert Einstein and Stephen Hawking. In a talk at the NC Biotechnology Center, she recounts her career and the opportunities she sees in the future for plant science - "the best of times and the worst of times."

Dr. Mary-Dell Chilton Dr. Mary-Dell Chilton

July 20

Premium Lock WTW wants your news - and your opinions: Share them with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

July 16

Premium Lock Two key state funding programs help life science companies get off the ground

(Photo courtesy of Asklepios BioPharmaceutical) Two key state funding programs are proving to be a great match to get new North Carolina life science companies off the ground.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith